New Perspectives in COPD Management

LEARNING OBJECTIVES
• Collaborate with patients to inform treatment decision-making that addresses their symptoms, goals, and concerns
• Individualize guideline-recommended therapy to reduce chronic obstructive pulmonary disease (COPD) exacerbations, improve lung function, manage daily symptoms such as breathlessness, and help achieve the patient’s goals
• Select an inhaler and an optimal dose of medication to best meet a patient’s needs and capabilities
KEY TAKEAWAYS
• The goal of treatment is to achieve and maintain stable disease by reducing both symptoms and the future risk of exacerbations.
• Holistic management consists of addressing 5 issues: 1) risk factors; 2) individualizing treatment; 3) comorbidities;
4) preventive therapy; and 5) self-management education to address patient’s goals and preferences.
• Patients with COPD most likely to experience benefit with an inhaled corticosteroid (ICS) include those with ≥2 exacerbations and/or 1 hospitalization in the previous year.
• There is a continuous relationship between blood eosinophils and ICS benefit with those with blood eosinophil count